NaV1.5 was found to be overexpressed in breast cancer biopsies compared to non-cancerous biopsies, associated with lymph node invasion, metastatic relapse and a decreased survival in patients (Fraser et al., 2005; Yang et al., 2012a). Here, SCN5A is linked to breast carcinoma.